Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1994 Apr;57(4):405–415. doi: 10.1136/jnnp.57.4.405

Meningitis.

H P Lambert
PMCID: PMC1072867  PMID: 8163987

Full text

PDF
405

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arditi M., Ables L., Yogev R. Cerebrospinal fluid endotoxin levels in children with H. influenzae meningitis before and after administration of intravenous ceftriaxone. J Infect Dis. 1989 Dec;160(6):1005–1011. doi: 10.1093/infdis/160.6.1005. [DOI] [PubMed] [Google Scholar]
  2. Arditi M., Manogue K. R., Caplan M., Yogev R. Cerebrospinal fluid cachectin/tumor necrosis factor-alpha and platelet-activating factor concentrations and severity of bacterial meningitis in children. J Infect Dis. 1990 Jul;162(1):139–147. doi: 10.1093/infdis/162.1.139. [DOI] [PubMed] [Google Scholar]
  3. Ashwal S., Stringer W., Tomasi L., Schneider S., Thompson J., Perkin R. Cerebral blood flow and carbon dioxide reactivity in children with bacterial meningitis. J Pediatr. 1990 Oct;117(4):523–530. doi: 10.1016/s0022-3476(05)80683-3. [DOI] [PubMed] [Google Scholar]
  4. Baldwin L. N., Henderson A., Thomas P., Wright M. Acute bacterial meningitis in young adults mistaken for substance abuse. BMJ. 1993 Mar 20;306(6880):775–776. doi: 10.1136/bmj.306.6880.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Belsey M. A., Hoffpauir C. W., Smith M. H. Dexamethasone in the treatment of acute bacterial meningitis: the effect of study design on the interpretation of results. Pediatrics. 1969 Oct;44(4):503–513. [PubMed] [Google Scholar]
  6. Bjune G., Høiby E. A., Grønnesby J. K., Arnesen O., Fredriksen J. H., Halstensen A., Holten E., Lindbak A. K., Nøkleby H., Rosenqvist E. Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet. 1991 Nov 2;338(8775):1093–1096. doi: 10.1016/0140-6736(91)91961-s. [DOI] [PubMed] [Google Scholar]
  7. Bohr V., Hansen B., Jessen O., Johnsen N., Kjersem H., Kristensen H. S., Nyboe J., Rasmussen N. Eight hundred and seventy-five cases of bacterial meningitis. Part I of a three-part series: clinical data, prognosis, and the role of specialised hospital departments. J Infect. 1983 Jul;7(1):21–30. doi: 10.1016/s0163-4453(83)90894-0. [DOI] [PubMed] [Google Scholar]
  8. Booy R., Hodgson S. A., Slack M. P., Anderson E. C., Mayon-White R. T., Moxon E. R. Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91). Arch Dis Child. 1993 Aug;69(2):225–228. doi: 10.1136/adc.69.2.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brandtzaeg P., Kierulf P., Gaustad P., Skulberg A., Bruun J. N., Halvorsen S., Sørensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 1989 Feb;159(2):195–204. doi: 10.1093/infdis/159.2.195. [DOI] [PubMed] [Google Scholar]
  10. Brisson-Noel A., Aznar C., Chureau C., Nguyen S., Pierre C., Bartoli M., Bonete R., Pialoux G., Gicquel B., Garrigue G. Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet. 1991 Aug 10;338(8763):364–366. doi: 10.1016/0140-6736(91)90492-8. [DOI] [PubMed] [Google Scholar]
  11. Broome C. V., Breiman R. F. Pneumococcal vaccine--past, present, and future. N Engl J Med. 1991 Nov 21;325(21):1506–1508. doi: 10.1056/NEJM199111213252109. [DOI] [PubMed] [Google Scholar]
  12. Cartwright K. A., Begg N. T., Hull D. Chemoprophylaxis for Haemophilus influenzae type b. BMJ. 1991 Mar 9;302(6776):546–547. doi: 10.1136/bmj.302.6776.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cartwright K. A. Vaccination against Haemophilus influenzae b disease. BMJ. 1992 Aug 29;305(6852):485–486. doi: 10.1136/bmj.305.6852.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cooke R. P., Riordan T., Jones D. M., Painter M. J. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7. BMJ. 1989 Mar 4;298(6673):555–558. doi: 10.1136/bmj.298.6673.555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. DeLemos R. A., Haggerty R. J. Corticosteroids as an adjunct to treatment in bacterial meningitis. A controlled clinical trial. Pediatrics. 1969 Jul;44(1):30–34. [PubMed] [Google Scholar]
  16. Fortnum H. M., Davis A. C. Epidemiology of bacterial meningitis. Arch Dis Child. 1993 Jun;68(6):763–767. doi: 10.1136/adc.68.6.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fortnum H. M. Hearing impairment after bacterial meningitis: a review. Arch Dis Child. 1992 Sep;67(9):1128–1133. doi: 10.1136/adc.67.9.1128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fortnum H., Davis A. Hearing impairment in children after bacterial meningitis: incidence and resource implications. Br J Audiol. 1993 Feb;27(1):43–52. doi: 10.3109/03005369309077889. [DOI] [PubMed] [Google Scholar]
  19. Friedland I. R., Klugman K. P. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet. 1992 Feb 15;339(8790):405–408. doi: 10.1016/0140-6736(92)90087-j. [DOI] [PubMed] [Google Scholar]
  20. Girgis N. I., Farid Z., Mikhail I. A., Farrag I., Sultan Y., Kilpatrick M. E. Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J. 1989 Dec;8(12):848–851. doi: 10.1097/00006454-198912000-00004. [DOI] [PubMed] [Google Scholar]
  21. Goh D., Minns R. A. Cerebral blood flow velocity monitoring in pyogenic meningitis. Arch Dis Child. 1993 Jan;68(1):111–119. doi: 10.1136/adc.68.1.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Howard A. J., Dunkin K. T., Musser J. M., Palmer S. R. Epidemiology of Haemophilus influenzae type b invasive disease in Wales. BMJ. 1991 Aug 24;303(6800):441–445. doi: 10.1136/bmj.303.6800.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Johnston S. R., Corbett E. L., Foster O., Ash S., Cohen J. Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis. J Infect. 1992 Mar;24(2):185–189. doi: 10.1016/0163-4453(92)92954-h. [DOI] [PubMed] [Google Scholar]
  24. Jones D. M. Control of meningococcal disease. BMJ. 1989 Mar 4;298(6673):542–543. doi: 10.1136/bmj.298.6673.542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kilpi T., Anttila M., Kallio M. J., Peltola H. Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet. 1991 Aug 17;338(8764):406–409. doi: 10.1016/0140-6736(91)91032-p. [DOI] [PubMed] [Google Scholar]
  26. Lebel M. H., Freij B. J., Syrogiannopoulos G. A., Chrane D. F., Hoyt M. J., Stewart S. M., Kennard B. D., Olsen K. D., McCracken G. H., Jr Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med. 1988 Oct 13;319(15):964–971. doi: 10.1056/NEJM198810133191502. [DOI] [PubMed] [Google Scholar]
  27. Lebel M. H., Hoyt M. J., Waagner D. C., Rollins N. K., Finitzo T., McCracken G. H., Jr Magnetic resonance imaging and dexamethasone therapy for bacterial meningitis. Am J Dis Child. 1989 Mar;143(3):301–306. doi: 10.1001/archpedi.1989.02150150055017. [DOI] [PubMed] [Google Scholar]
  28. Mellor D. H. The place of computed tomography and lumbar puncture in suspected bacterial meningitis. Arch Dis Child. 1992 Dec;67(12):1417–1419. doi: 10.1136/adc.67.12.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Mustafa M. M., Lebel M. H., Ramilo O., Olsen K. D., Reisch J. S., Beutler B., McCracken G. H., Jr Correlation of interleukin-1 beta and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr. 1989 Aug;115(2):208–213. doi: 10.1016/s0022-3476(89)80067-8. [DOI] [PubMed] [Google Scholar]
  30. Mustafa M. M., Ramilo O., Mertsola J., Risser R. C., Beutler B., Hansen E. J., McCracken G. H., Jr Modulation of inflammation and cachectin activity in relation to treatment of experimental Hemophilus influenzae type b meningitis. J Infect Dis. 1989 Nov;160(5):818–825. doi: 10.1093/infdis/160.5.818. [DOI] [PubMed] [Google Scholar]
  31. Peltola H., Anttila M., Renkonen O. V. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet. 1989 Jun 10;1(8650):1281–1287. doi: 10.1016/s0140-6736(89)92685-8. [DOI] [PubMed] [Google Scholar]
  32. Peltola H., Kilpi T., Anttila M. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines. Lancet. 1992 Sep 5;340(8819):592–594. doi: 10.1016/0140-6736(92)92117-x. [DOI] [PubMed] [Google Scholar]
  33. Peltola H., Käyhty H., Virtanen M., Mäkelä P. H. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med. 1984 Jun 14;310(24):1561–1566. doi: 10.1056/NEJM198406143102404. [DOI] [PubMed] [Google Scholar]
  34. Powderly W. G., Saag M. S., Cloud G. A., Robinson P., Meyer R. D., Jacobson J. M., Graybill J. R., Sugar A. M., McAuliffe V. J., Follansbee S. E. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med. 1992 Mar 19;326(12):793–798. doi: 10.1056/NEJM199203193261203. [DOI] [PubMed] [Google Scholar]
  35. Powell K. R., Sugarman L. I., Eskenazi A. E., Woodin K. A., Kays M. A., McCormick K. L., Miller M. E., Sladek C. D. Normalization of plasma arginine vasopressin concentrations when children with meningitis are given maintenance plus replacement fluid therapy. J Pediatr. 1990 Oct;117(4):515–522. doi: 10.1016/s0022-3476(05)80682-1. [DOI] [PubMed] [Google Scholar]
  36. Pécoul B., Varaine F., Keita M., Soga G., Djibo A., Soula G., Abdou A., Etienne J., Rey M. Long-acting chloramphenicol versus intravenous ampicillin for treatment of bacterial meningitis. Lancet. 1991 Oct 5;338(8771):862–866. doi: 10.1016/0140-6736(91)91511-r. [DOI] [PubMed] [Google Scholar]
  37. Quagliarello V., Scheld W. M. Bacterial meningitis: pathogenesis, pathophysiology, and progress. N Engl J Med. 1992 Sep 17;327(12):864–872. doi: 10.1056/NEJM199209173271208. [DOI] [PubMed] [Google Scholar]
  38. Radetsky M. Duration of symptoms and outcome in bacterial meningitis: an analysis of causation and the implications of a delay in diagnosis. Pediatr Infect Dis J. 1992 Sep;11(9):694–701. doi: 10.1097/00006454-199209000-00002. [DOI] [PubMed] [Google Scholar]
  39. Rennick G., Shann F., de Campo J. Cerebral herniation during bacterial meningitis in children. BMJ. 1993 Apr 10;306(6883):953–955. doi: 10.1136/bmj.306.6883.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Saag M. S., Powderly W. G., Cloud G. A., Robinson P., Grieco M. H., Sharkey P. K., Thompson S. E., Sugar A. M., Tuazon C. U., Fisher J. F. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992 Jan 9;326(2):83–89. doi: 10.1056/NEJM199201093260202. [DOI] [PubMed] [Google Scholar]
  41. Schaad U. B., Lips U., Gnehm H. E., Blumberg A., Heinzer I., Wedgwood J. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet. 1993 Aug 21;342(8869):457–461. doi: 10.1016/0140-6736(93)91592-a. [DOI] [PubMed] [Google Scholar]
  42. Tureen J. H., Dworkin R. J., Kennedy S. L., Sachdeva M., Sande M. A. Loss of cerebrovascular autoregulation in experimental meningitis in rabbits. J Clin Invest. 1990 Feb;85(2):577–581. doi: 10.1172/JCI114475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Täuber M. G., Shibl A. M., Hackbarth C. J., Larrick J. W., Sande M. A. Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits. J Infect Dis. 1987 Sep;156(3):456–462. doi: 10.1093/infdis/156.3.456. [DOI] [PubMed] [Google Scholar]
  44. Viladrich P. F., Gudiol F., Liñares J., Pallarés R., Sabaté I., Rufí G., Ariza J. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991 Dec;35(12):2467–2472. doi: 10.1128/aac.35.12.2467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Viladrich P. F., Pallares R., Ariza J., Rufi G., Gudiol F. Four days of penicillin therapy for meningococcal meningitis. Arch Intern Med. 1986 Dec;146(12):2380–2382. [PubMed] [Google Scholar]
  46. de Moraes J. C., Perkins B. A., Camargo M. C., Hidalgo N. T., Barbosa H. A., Sacchi C. T., Landgraf I. M., Gattas V. L., Vasconcelos H. de G., Gral I. M. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet. 1992 Oct 31;340(8827):1074–1078. doi: 10.1016/0140-6736(92)93086-3. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES